|
Orthologous residues
|
|
SKP2 (human): S64‑p, SKP2 (mouse): S64‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, immunoprecipitation, mutation of modification site, western blotting
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial), HeLa (cervical)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
Pim1 (human)
|
transfection of wild-type enzyme, pharmacological inhibitor of upstream enzyme, co-immunoprecipitation
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
roscovitine
|
|
|
|
decrease
|
|
|
wortmannin
|
|
|
|
decrease
|
|
|
SMI-4a
|
|
|
|
decrease
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
activation, phosphorylation, protein stabilization, ubiquitination
|
|
Effect of modification (process):
cell cycle regulation
|
|
Comments:
p27 degradation; required for T417 phosphorylation
|